TG-693 is an orally active CLK1 (CDC2-like kinase 1) inhibitor that promotes exon 31 skipping of the dystrophin gene mutation in vivo and inhibits CLK1 substrate phosphorylation, suitable for studying Duchenne muscular dystrophy (DMD).
Molecular Weight:
195.23
Purity:
99.81%
CAS Number:
[885272-55-9]
Formula:
C12H9N3
Target:
CDK
T66481
* VAT and and shipping costs not included. Errors and price changes excepted
